Press release
Alzheimer's Drugs Market on Track for Strong Growth, Estimated to Grow at 9.2% CAGR Through 2029
Alzheimer's Drugs Market
What Is the Expected CAGR for the Alzheimer's Drugs Market Through 2025?
The market size for Alzheimer's medication has seen a robust expansion in recent times. This growth is expected to continue, escalating from $9.33 billion in 2024 to $10.19 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.1%. Factors contributing to this historical growth include an increase in reported Alzheimer's disease cases, substantial investments in research and development, enhanced knowledge of disease mechanisms, worldwide health initiatives, and public awareness and education.
What's the Projected Size of the Global Alzheimer's Drugs Market by 2029?
In the upcoming years, substantial growth is anticipated for the Alzheimer's drugs market, which is estimated to reach $14.47 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 9.2%. The growth predicted for this period can be accredited to precision medicine methodologies, emphasis on disease alteration, the identification and affirmation of biomarkers, patient-focused drug development, and the concentration on non-pharmacological interventions. During this forecasted period, major advancements are expected in the form of varied therapeutic methods, digital healthcare solutions, regenerative medicine, advancements in diagnostic technologies, the utilization of artificial intelligence (AI) in drug discovery, and partnerships and collaborations.
View the full report here:
https://www.thebusinessresearchcompany.com/report/alzheimers-drugs-global-market-report
Top Growth Drivers in the Alzheimer's Drugs Industry: What's Accelerating the Market?
The escalating occurrence of Alzheimer's disease is projected to fuel the expansion of the Alzheimer's drugs market. Alzheimer's disease is a neurological disorder that progressively deteriorates, leading to brain shrinkage and cell death. Medications for Alzheimer's are utilized to address memory loss, thinking problems, and complications in routine living. These drugs can improve life quality and help retain independence. For example, a report from the Alzheimer's Association, a US-based nonprofit committed to Alzheimer's care, support, and research, noted that the count of Americans aged 65 and above diagnosed with Alzheimer's dementia surged from 6.5 million in 2022 to a projected 6.9 million in May 2024. Therefore, the surging occurrence of Alzheimer's disease is pushing the growth of the Alzheimer's drugs market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9040&type=smp
What Trends Will Shape the Alzheimer's Drugs Market Through 2029 and Beyond?
Leading enterprises in the Alzheimer's medication market are revolutionizing product development with inventions like amyloid plaque-targeting therapy, with the aim of enhancing treatment methods and bettering the outcomes for patients. The aforementioned therapy is an Alzheimer's treatment technique that emphasizes the reduction or halting of amyloid-beta plaque build-up in the brain. For instance, Eli Lilly and Company, an American pharmaceutical firm, was granted approval for Kisunla (donanemab-azbt) by the FDA, the US-based federal agency tasked with safeguarding public health, in June 2024. Tailored as the sole available amyloid plaque-targeting treatment for the early symptomatic stages of Alzheimer's, Kisunla functions by assisting the body in ridding the brain of surplus amyloid plaques that have been linked with cognitive degeneration in Alzheimer's patients. This drug is delivered via an intravenous drip every four weeks, with the first three doses being 700 mg each, followed by 1400 mg doses subsequently. Kisunla is expressly prescribed for adults diagnosed with mild cognitive impairment (MCI) and the mild dementia stage of Alzheimer's, given that they have established amyloid pathology.
What Are the Main Segments in the Alzheimer's Drugs Market?
The alzheimer's drugs market covered in this report is segmented -
1) By Drugs: Donepezil, Rivastigmine, Galantamine, Memantine
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
3) By Application: Early To Moderate Stages, Moderate To Severe Stages
Subsegments:
1) By Donepezil: Oral Tablets, Oral Solution
2) By Rivastigmine: Oral Capsules, Oral Solution, Transdermal Patches
3) By Galantamine: Oral Tablets, Oral Solution, Extended-Release Capsules
4) By Memantine: Oral Tablets, Oral Solution, Extended-Release Capsules
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9040&type=smp
Which Top Companies are Driving Growth in the Alzheimer's Drugs Market?
Major companies operating in the alzheimer's drugs market include AbbVie Inc., Daiichi Sankyo Company Limited, F Hoffmann-La Roche AG, Merck & Co Inc., Novartis AG, Biogen Inc., AstraZeneca PLC, Eisai Co Ltd., Eli Lilly and Company, H Lundbeck A/S, Pfizer Inc., Allergan PLC., Johnson & Johnson, Lupin Pharmaceuticals Inc., Actiza Pharmaceutical Private Limited, Neurotrope Inc., AC Immune SA, Adamas Pharmaceuticals Inc, Alzheon Inc., Anavex Life Sciences Corp, Axsome Therapeutics Inc., Cassava Sciences Inc., Cognition Therapeutics Inc., Cortexyme Inc., Denali Therapeutics Inc, EIP Pharma Inc., Enlivex Therapeutics Ltd., FORUM Pharmaceuticals Inc., Genentech Inc., Green Valley Pharmaceuticals LLC, Intra-Cellular Therapies Inc., Karuna Therapeutics Inc., Neurim Pharmaceuticals Ltd
Which Regions Will Dominate the Alzheimer's Drugs Market Through 2029?
North Americawas the largest region in the Alzheimer's drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the Alzheimer's drugs market during the forecast period. The regions covered in the Alzheimer's drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9040
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Alzheimer's Drugs Market on Track for Strong Growth, Estimated to Grow at 9.2% CAGR Through 2029 here
News-ID: 4088098 • Views: …
More Releases from The Business Research Company
Emerging Trends to Reshape the Xenotransplantation Market: Xvivo's Innovative Pr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Xenotransplantation Market Size By 2025?
The market size of xenotransplantation has seen robust expansion in the past few years. The market value is projected to increase from $14.68 billion in 2024 to $15.82 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 7.8%.…
Wood Based Panel Market Landscape to 2034: Key Forces Shaping the Next Decade of …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Wood Based Panel Market Through 2025?
In recent times, the market size of wood-based panels has seen considerable growth. The market which was valued at $176.85 billion in 2024 is projected to rise to $190.52 billion in 2025, showing a compound annual…
Soaring Demand Set to Propel Wireless Speakers Market to $111.25 Billion by 2029
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Wireless Speakers Market Size Growth Forecast: What to Expect by 2025?
In recent times, the wireless speakers market has experienced substantial expansion. The market size is expected to increase from $37.14 billion in 2024 to $45.71 billion in 2025, growing at a compound annual growth rate (CAGR) of 23.1%.…
Wind Turbine Casting Market Landscape 2025: Forecast Data and Growth Strategy In …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Wind Turbine Casting Industry Market Size Be by 2025?
The market size for wind turbine castings has seen solid growth in the past few years. Its value is projected to increase from $2.31 billion in 2024 to $2.46 billion in 2025, with a compound annual growth…
More Releases for Alzheimer
Dementia - Alzheimer Disease Market: A Comprehensive Analysis 2030
Dementia and Alzheimer's disease represent significant challenges within the global healthcare sector. These neurological disorders, characterized by progressive cognitive decline, have seen increasing prevalence due to aging populations worldwide. This growing burden has spurred interest in the Dementia - Alzheimer's disease market, encompassing diagnostic tools, treatments, caregiving solutions, and related healthcare services. This article provides an overview of the market, its scope, current trends, and factors driving its expansion.
Data Bridge…
Alzheimer Disease Treatment Market | Allergan, Amgen, Daiichi Sankyo, Eisai
The global alzheimer disease treatment market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the alzheimer disease treatment market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
United States Alzheimer Drugs Market Insights Deep Analysis 2023-2031
Cognate Life Sciences introduces a report on "United States Alzheimer Drugs Market 2023" with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also talks about crucial pockets of the industry such as products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context and more. It conjointly…
Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe …
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors is…
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,…
Global Alzheimer Market Report: 2015 Edition | Now Available at Researchmoz.us
Researchmoz added Most up-to-date research on "Global Alzheimer Market Report: 2015 Edition" to its huge collection of research reports.
Alzheimer’s disease is defined as an advanced neurological disorder that increasingly deprives patients of their memory and ability to carry out daily activities. As it grows in a human brain, individuals are likely to practice difficulties in linguistic, agility and insight along with negative changes in the character and performance such as…
